Prime Medicine Launches With $315m To Fund New Approach To Gene Editing

 
• By Alaric DeArment
DNA helix
Gene-editing company Prime Medicine launches with $315m in financing from two funding rounds • Source: Shutterstock

More from Gene Therapies

More from Advanced Therapies